Park; Myung-Ok

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Myung-Ok.The latest application filed is for "cationic lipids, methods for preparing the same, and delivery systems having ability to transition into cells comprising the same".

Company Profile

0.9.14

Park; Myung-Ok - Seoul N/A KR
Park; Myung-Ok - Nowon-gu KR
Park; Myung-Ok - 139-230 Seoul KR
Park, Myung-Ok - Sungbuk-gu KR
Park; Myung-Ok - Nowon-ku 139-230 KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biopolymer conjugates comprising an interleukin-11 analog Grant 8,716,446 - Jung , et al. May 6, 2	2014-05-06
Cationic Lipids, Methods For Preparing The Same, And Delivery Systems Having Ability To Transition Into Cells Comprising The Same App 20130123485 - Park; Myung-Ok ; et al.	2013-05-16
Chitosan based polymer conjugate and a method for producing the same Grant 8,431,543 - Park , et al. April 30, 2	2013-04-30
siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same Grant 8,242,094 - Park , et al. August 14, 2	2012-08-14
Sirna Of Nf-kb P105 For Inhibiting Cell Proliferation And Migration And A Composition Comprising Same App 20110280929 - Park; Myung-Ok ; et al.	2011-11-17
Chitosan Based Polymer Conjugate and a Method for Producing the Same App 20100113559 - Park; Myung-Ok ; et al.	2010-05-06
Biopolymer Conjugates Comprising an Interleukin-11 Analog App 20100098658 - JUNG; Yuni ; et al.	2010-04-22
Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF Grant 7,557,195 - Park July 7, 2	2009-07-07
Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis Grant 7,413,735 - Min , et al. August 19, 2	2008-08-19
Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same App 20070117924 - Park; Myung-Ok	2007-05-24
Human growth hormone conjugated with biocompatible polymer App 20060134736 - Jacobs; John W. ; et al.	2006-06-22
Biocompatible polymers including peptide spacer Grant 7,049,285 - Park May 23, 2	2006-05-23
Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis App 20060002915 - Min; Bon-Hong ; et al.	2006-01-05
Human growth hormone conjugated with biocompatible polymer App 20050281778 - Park, Myung-Ok ; et al.	2005-12-22
Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue App 20050143563 - Park, Myung-Ok	2005-06-30
Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same App 20050059129 - Park, Myung-Ok	2005-03-17
Biologically active non-antigenic copolymer and conjugates thereof and methods for producing the same App 20040105839 - Park, Myung-Ok	2004-06-03
Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis App 20040096437 - Min, Bon-Hong ; et al.	2004-05-20
Biocompatible polymers including peptide spacer App 20030185798 - Park, Myung-Ok	2003-10-02
Nasal transmucosal delivery of peptide conjugated with biocompatible polymers Grant 6,506,730 - Lee , et al. January 14, 2	2003-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.